The 2-Stage Liver Transplant: 3 Clinical Scenarios
dc.authorid | Toprak, Hüseyin İlksen/0000-0001-9293-8116 | |
dc.authorid | Gedik, Ender/0000-0002-7175-207X | |
dc.authorid | Isik, Burak/0000-0002-2395-3985 | |
dc.authorid | Kayaalp, Cuneyt/0000-0003-4657-2998 | |
dc.authorwosid | Toprak, Hüseyin İlksen/AAN-4023-2020 | |
dc.authorwosid | bıçakcıoğlu, murat/ABB-5579-2020 | |
dc.authorwosid | Gedik, Ender/ABI-2971-2020 | |
dc.authorwosid | Kayaalp, Cuneyt/AAH-1764-2021 | |
dc.authorwosid | Isik, Burak/A-6657-2018 | |
dc.contributor.author | Gedik, Ender | |
dc.contributor.author | Bicakcioglu, Murat | |
dc.contributor.author | Otan, Emrah | |
dc.contributor.author | Toprak, Huseyin Ilksen | |
dc.contributor.author | Isik, Burak | |
dc.contributor.author | Aydin, Cemalettin | |
dc.contributor.author | Kayaalp, Cuneyt | |
dc.date.accessioned | 2024-08-04T20:41:08Z | |
dc.date.available | 2024-08-04T20:41:08Z | |
dc.date.issued | 2015 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description | 14th Congress of the Middle-East-Society-for-Organ-Transplantation / 5th Middle East Transplant Games -- SEP 10-13, 2014 -- Istanbul, TURKEY | en_US |
dc.description.abstract | The main goal of 2-stage liver transplant is to provide time to obtain a new liver source. We describe our experience of 3 patients with 3 different clinical conditions. A 57-year-old man was retransplanted successfully with this technique due to hepatic artery thrombosis. However, a 38-year-old woman with fulminant toxic hepatitis and a 5-year-old-boy with abdominal trauma had poor outcome. This technique could serve as a rescue therapy for liver transplant patients who have toxic liver syndrome or abdominal trauma. These patients required intensive support during long anhepatic states. The transplant team should decide early whether to use this technique before irreversible conditions develop. | en_US |
dc.identifier.doi | 10.6002/ect.mesot2014.P135 | |
dc.identifier.endpage | 289 | en_US |
dc.identifier.issn | 1304-0855 | |
dc.identifier.pmid | 25894175 | en_US |
dc.identifier.scopus | 2-s2.0-84939814892 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 286 | en_US |
dc.identifier.uri | https://doi.org/10.6002/ect.mesot2014.P135 | |
dc.identifier.uri | https://hdl.handle.net/11616/96938 | |
dc.identifier.volume | 13 | en_US |
dc.identifier.wos | WOS:000355058400059 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Baskent Univ | en_US |
dc.relation.ispartof | Experimental and Clinical Transplantation | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Deceased donor | en_US |
dc.subject | End-stage liver disease | en_US |
dc.subject | Living donor | en_US |
dc.subject | Retransplant | en_US |
dc.subject | Toxic liver syndrome | en_US |
dc.title | The 2-Stage Liver Transplant: 3 Clinical Scenarios | en_US |
dc.type | Conference Object | en_US |